4//SEC Filing
Casdin Capital, LLC 4
Accession 0000919574-25-006180
CIK 0000834365other
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 7:55 PM ET
Size
11.3 KB
Accession
0000919574-25-006180
Insider Transaction Report
Form 4
Casdin Capital, LLC
10% Owner
Transactions
- Sale
Common Stock, par value $0.001 per share
2025-10-15$28.55/sh−750,000$21,410,325→ 5,957,165 total(indirect: Footonote)
Casdin Eli
10% Owner
Transactions
- Sale
Common Stock, par value $0.001 per share
2025-10-15$28.55/sh−750,000$21,410,325→ 5,957,165 total(indirect: Footonote)
Casdin Partners GP, LLC
10% Owner
Transactions
- Sale
Common Stock, par value $0.001 per share
2025-10-15$28.55/sh−750,000$21,410,325→ 5,957,165 total(indirect: Footonote)
Casdin Partners Master Fund, L.P.
10% Owner
Transactions
- Sale
Common Stock, par value $0.001 per share
2025-10-15$28.55/sh−750,000$21,410,325→ 5,957,165 total(indirect: Footonote)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $28.50 to $28.8354. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The securities are owned directly by Casdin Partners Master Fund, L.P. (the "Master Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC ("Casdin Capital"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC ("Casdin GP"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin Capital and Casdin GP.
Documents
Issuer
BIOLIFE SOLUTIONS INC
CIK 0000834365
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001534261
Filing Metadata
- Form type
- 4
- Filed
- Oct 16, 8:00 PM ET
- Accepted
- Oct 17, 7:55 PM ET
- Size
- 11.3 KB